Business Segments · D&A
Pharmaceutical and Specialty Solutions — D&A
Cardinal Health Pharmaceutical and Specialty Solutions — D&A increased by 9.4% to $70.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 59.1%, from $44.00M to $70.00M. Over 3 years (FY 2022 to FY 2025), Pharmaceutical and Specialty Solutions — D&A shows relatively stable performance with a 2.9% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ3 2021
Last reportedQ1 2026
Rolls up toD&A
How to read this metric
High levels suggest significant capital investment in infrastructure, while low levels may indicate aging assets.
Detailed definition
The non-cash expense allocated to the Pharmaceutical and Specialty Solutions segment to account for the wear and tear of...
Peer comparison
Standard accounting metric for capital-intensive distribution businesses.
Metric ID:
cah_segment_pharmaceutical_and_specialty_solutions_depreciation_and_amortizationHistorical Data
19 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $42.50M | $42.50M | $42.50M | $42.50M | $48.50M | $48.50M | $48.50M | $48.50M | $46.00M | $46.00M | $46.00M | $46.00M | $27.00M | $46.00M | $44.00M | $68.00M | $61.00M | $64.00M | $70.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +14.1% | +0.0% | +0.0% | +0.0% | -5.2% | +0.0% | +0.0% | +0.0% | -41.3% | +70.4% | -4.3% | +54.5% | -10.3% | +4.9% | +9.4% |
| YoY Change | — | — | — | — | +14.1% | +14.1% | +14.1% | +14.1% | -5.2% | -5.2% | -5.2% | -5.2% | -41.3% | +0.0% | -4.3% | +47.8% | +125.9% | +39.1% | +59.1% |
Range$27.00M – $70.00M
CAGR+11.7%
Avg YoY Growth+17.5%
Median YoY Growth+14.1%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's pharmaceutical and specialty solutions — d&a?
- Cardinal Health (CAH) reported pharmaceutical and specialty solutions — d&a of $70.00M in Q1 2026.
- How has Cardinal Health's pharmaceutical and specialty solutions — d&a changed year-over-year?
- Cardinal Health's pharmaceutical and specialty solutions — d&a increased by 59.1% year-over-year, from $44.00M to $70.00M.
- What is the long-term trend for Cardinal Health's pharmaceutical and specialty solutions — d&a?
- Over 3 years (2022 to 2025), Cardinal Health's pharmaceutical and specialty solutions — d&a has grown at a 2.9% compound annual growth rate (CAGR), from $170.00M to $185.00M.
- What does pharmaceutical and specialty solutions — d&a mean?
- The non-cash cost representing the gradual wear of equipment and the expiration of intangible assets in the segment.